On-Demand Cell Line Development Webinars

1. Breaking the Titer Ceiling: Smarter Media Design for Higher Productivity 6/30/2026

   A bottom-up, data-driven media design approach shows how targeted nutrient optimization overcomes metabolic limits to boost culture performance and titer while maintaining product quality and process consistency.

2. Generate Stable High-Producing Clones In 14 Weeks 6/18/2026

   Rising complexity is putting pressure on cell line development. Discover a streamlined approach that enables rapid generation of stable clones with strong titers and long-term consistency.

3. Elevate Your Protein Production With SynWeave™ 6/15/2026

   Sunit Maity, Ph.D., Senior GM – Biologics Services, introduces an advanced platform that combines state-of-the-art cell line and transposon-based technologies from ExcellGene.

4. Streamlining Discovery And Development Workflows Using Engineered P. fluorescens Strains For ncAA Incorporation And Extracellular Protein Production 6/8/2026

   Pseudomonas fluorescens offers a purpose-built alternative to conventional expression systems. Strain engineering platforms built around this organism can improve yields and simplify process development.

5. Accelerating Antibody Development: A Proven Path From Gene To GMP 6/5/2026

   Discover how an optimized, end-to-end development strategy can help sponsors reach key clinical milestones faster and bring potentially life-saving therapies to patients sooner.

6. From Gene Editing To NGS-Based T Cell Characterization 6/4/2026

   Gene-edited T cells targeting PD-1 and TIGIT are redefining approaches to cancer therapy. Explore how cell engineering and integrated genomic workflows uncover critical insights into T cell function.

7. Faster Clones, Simpler Process: What's Changing In CHO Expression? 6/3/2026

   This presentation examines how enhanced glutamine synthetase selection stringency, combined with a high-strength gene promoter, provides greater control over gene expression and supports CHO cell line development.

8. Advancing Next Gen Antibodies: From AI Driven CLD To Manufacturing 6/2/2026

   See how growing ADC complexity is driving the adoption of AI-enabled, data-driven CMC strategies that accelerate development, improve product insight, and strengthen manufacturing readiness.

9. Advancing Therapeutic Discovery With High-Throughput Electroporation 5/21/2026

   Learn how high-throughput electroporation streamlines genetic material delivery for cell therapy and drug discovery, offering speed, precision, and scalability across hard-to-transfect cell types.

10. From DNA To IND In As Little As 6 Months 4/27/2026

    Discover how an integrated, platform-driven CMC approach can accelerate your antibody program from DNA to IND in as little as six months while reducing risk and maintaining quality and regulatory alignment.